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The U.S. Centers for Disease Control and Prevention (CDC) previously issued travel, testing, and other guidance 
related to areas of active Zika virus transmission in Florida. Because local transmission of Zika virus continues to 
be reported in Miami-Dade County, CDC is strengthening travel recommendations for pregnant women to Miami-
Dade County and also reinforcing recommendations for use of protective measures to prevent exposure to Zika. 
CDC is updating recommendations to emphasize testing for pregnant women with an epidemiologic link to Miami-
Dade County. An epidemiologic link means that they lived in, traveled to, or had unprotected sex with someone 
who lived in or traveled to, the designated area. In addition, CDC has made specific recommendations for areas 
of identified active transmission.   
 
The Florida Department of Health (FL DOH) has identified a new area where local, state, and CDC officials have 
determined that the intensity of Zika virus transmission presents a significant risk to pregnant women in a 
designated one-square-mile area located in Miami-Dade County (NW 79th St. to the north, NW 63rd St. to the 
south, NW 10th Ave. to the west and N. Miami Ave. to the east).   
 
• Pregnant women should consider postponing travel to all areas of Miami-Dade County. Pregnant women 
should specifically avoid travel to the previously identified 4.5-square-mile area of Miami Beach and one-
square-mile area in Little River located in Miami-Dade County (http//www.cdc.gov/zika/intheus/florida-
update.html).  
 
• Pregnant women who have an epidemiologic link to any area of Miami-Dade County after August 1, 2016 
should be tested for Zika virus in accordance with CDC guidance 
(http://www.cdc.gov/mmwr/volumes/65/wr/mm6529e1.htm?s_cid=mm6529e1_e). 
o Pregnant women with an epidemiologic link to the 4.5-square-mile area of Miami Beach with 
active Zika virus transmission, after July 14, 2016, should be tested for Zika virus. 
 
Because the incubation period for Zika virus infection is up to two weeks and many people infected with Zika virus 
will not have symptoms or will only have mild symptoms, investigating cases may take several weeks. Data 
collected during the ongoing investigation indicate the period of time since August 1 represents the timeframe with 
the highest transmission in Miami-Dade County.  
 
FL DOH and CDC continue to work together on this ongoing investigation to learn more about active Zika virus 
transmission in Miami-Dade County. CDC will update these recommendations as more information becomes 





Red and Yellow Area Designation 
CDC has defined two types of geographic areas within the continental United States and Hawaii to implement 
measures to prevent Zika virus transmission: Zika active transmission areas (designated as red) and Zika 
cautionary areas (designated as yellow).  
 
• A red area is a geographic area where local, state, and CDC officials have determined that the intensity 
of Zika virus transmission presents a significant risk to pregnant women. The intensity of Zika virus 
transmission is determined by several factors including geographic distribution of cases, number of cases 
identified, known or suspected links between cases and population density.  
• A yellow area is a geographic area where local transmission has been identified, but evidence is lacking 
on whether the intensity of transmission is comparable to that in a red area. Although the level of risk in 
yellow areas is unknown, pregnant women are still at risk. Additionally, areas adjacent to or in proximity to 
red areas may have a greater likelihood of local transmission and, therefore, risk to pregnant women.  
 
Currently, a 4.5-square-mile area of Miami Beach and one-square-mile area in Little River located in Miami-Dade 
County (http//www.cdc.gov/zika/intheus/florida-update.html) are red areas and the rest of Miami-Dade County is a 
yellow area. Because this investigation is ongoing and the designation of areas is likely to change over time, 
please frequently check the website (http//www.cdc.gov/zika/intheus/florida-update.html) for the most up-to-date 
designation of red and yellow areas.  
 
Recommendations for Miami-Dade County   
 
Travel Recommendations for Pregnant Women 
1. Pregnant women should consider postponing travel to yellow areas of Miami-Dade County. 
 
2. Pregnant women should specifically avoid travel to red areas (http//www.cdc.gov/zika/intheus/florida-
update.html) because the intensity of Zika virus transmission confirmed in these areas presents a 
significant risk to pregnant women. 
  
 
Testing Recommendations for Pregnant Women 
1.   Pregnant women with an epidemiologic link to Miami-Dade County after August 1, 2016, should be tested 
for Zika virus infection in accordance with CDC guidance. Pregnant women with an epidemiologic link to 
the 4.5-square-mile area of Miami Beach with active Zika virus transmission after July 14, 2016, should 
be tested for Zika virus (http://www.cdc.gov/mmwr/volumes/65/wr/mm6529e1.htm?s_cid=mm6529e1_e).  
a. Pregnant women with symptoms of Zika virus disease should be tested according to CDC guidance, 
which is based on the time of evaluation relative to symptom onset. 
b. Pregnant women with ongoing exposure (who live in or frequently travel [e.g., daily, weekly]) to 
Miami-Dade County and who are without symptoms of Zika virus disease should consult with their 
healthcare provider to obtain testing for Zika virus infection in the first and second trimesters of 
pregnancy.  
c. Pregnant women who have had limited travel to or had sex without using a condom with a partner 
who lives in or has traveled to Miami-Dade County should be tested for Zika virus infection. This 
testing should be performed based on the time of evaluation relative to last possible exposure in 
accordance with CDC guidance. 
 
2. Healthcare providers should contact their state, local, or territorial health department to coordinate 
testing and interpret results. Healthcare providers should discuss the limitations of laboratory tests used 
to diagnose Zika virus infection with pregnant women and their partners. 
 
Protective Measures Recommendations for Pregnant Women 
1. Pregnant women and their partners living in or traveling to Miami-Dade County should be aware of active 
Zika virus transmission and should strictly follow steps to prevent mosquito bites. 
(http://www.cdc.gov/zika/prevention/prevent-mosquito-bites.html). 
 
2. Women and men who live in or travel to Miami-Dade County should be aware of active Zika virus 
transmission, and those who are pregnant or have a pregnant sex partner should consistently and 




Women and Men Who are Planning to Conceive 
1. Women and men who are planning to conceive in the near future should consider avoiding nonessential travel 
to red areas. 
 
2. Women with an epidemiologic link to the red areas and who do not have ongoing risks for exposure should 
wait at least eight weeks after symptom onset (if symptomatic) or after last possible exposure (if 
asymptomatic) to attempt conception. 
 
3. Men with an epidemiologic link to the red areas who do not have ongoing risks for exposure should wait at 
least six months after symptom onset (if symptomatic) or last possible exposure (if asymptomatic) to attempt 
conception. 
 
4. Women with an epidemiologic link to the yellow areas who do not have ongoing risks for exposure may 
consider waiting at least eight weeks from symptom onset (if symptomatic) or last possible exposure (if 
asymptomatic) to attempt conception. Although the level of risk in yellow areas is unknown, pregnant women 
are still at risk. Additionally, areas adjacent to or in proximity to red areas may have a greater likelihood of 
local transmission, so there may be a greater risk to pregnant women. 
 
5. Men with an epidemiologic link to the yellow areas who do not have ongoing risks for exposure may consider 
waiting at least six months from symptom onset (if symptomatic) or last possible exposure (if asymptomatic) 
to attempt conception. Although the level of risk in yellow areas is unknown, pregnant women are still at risk. 
Additionally, areas adjacent to or in proximity to red areas may have a greater likelihood of local transmission, 
so there may be a greater risk to pregnant women. 
 
6. People living in an area with possible Zika virus transmission should be counseled on the possible risk for 
Zika virus infection during the periconception period. Women and men should discuss their reproductive life 
plans with their healthcare provider in the context of potential and ongoing Zika virus exposure. Women and 
men with ongoing risks for exposure who are diagnosed with Zika virus disease should wait at least eight 
weeks and at least six months respectively, after symptom onset before attempting conception. 
 
7. There are limited data about the persistence of Zika virus RNA in body fluids, and the risk for adverse 
pregnancy outcomes associated with maternal Zika virus infection around the time of conception is currently 
not known. Given this information, some couples in which one or both partners have had a possible Zika virus 
exposure might choose to wait longer or shorter than the recommended period to conceive, depending on 
individual circumstances (e.g., age, fertility, details of possible exposure) and risk tolerance. 
 
8. Women and men attempting conception living in or traveling to the Miami-Dade County should be aware of 




Additional Recommendations  
For the yellow area, additional Zika-related interventions (e.g., testing of symptomatic non-pregnant persons) may 
be implemented depending on local circumstances.  
 
Background 
Zika virus is spread to people primarily through the bite of an infected Aedes species mosquito (Ae. aegypti and 
Ae. albopictus). Zika virus can also be sexually transmitted. Zika virus infection during pregnancy is a cause of 
microcephaly and severe fetal brain defects and has been associated with other adverse pregnancy outcomes. 
Most people infected with Zika virus will not have symptoms; infants with microcephaly and other birth defects 
have been born to women with Zika virus infection who did not report symptoms. 
 
For pregnant women who report clinical illness consistent with Zika virus disease (symptomatic pregnant women), 
CDC's testing recommendations are the same for those with ongoing risk and those with limited risk for possible 
Zika virus exposure. Symptomatic pregnant women who are evaluated less than two weeks after symptom onset 
should receive serum and urine Zika virus RNA nucleic acid test (NAT) testing. Symptomatic pregnant women 
who are evaluated 2 to 12 weeks after symptom onset should first receive a Zika virus immunoglobulin (Ig) M 
antibody test; if the IgM antibody test result is positive or equivocal (unclear), serum and urine RNA NAT testing 
should be performed. If the RNA NAT result is negative, a positive or equivocal (unclear) Zika virus IgM antibody 
test result should be followed by plaque reduction neutralization testing (PRNT). Interpretation of serologic results 
has been described (http://www.cdc.gov/mmwr/volumes/65/wr/mm6521e1.htm).   
 
Testing recommendations for pregnant women with possible Zika virus exposure who do not report clinical illness 
consistent with Zika virus disease (asymptomatic pregnant women) differ based on the circumstances of possible 
exposure. For asymptomatic pregnant women with ongoing risk for possible exposure who are evaluated less 
than two weeks after last possible exposure, RNA NAT testing should be performed. If the RNA NAT result is 
negative, a Zika virus IgM antibody test should be performed 2 to 12 weeks after the exposure. Asymptomatic 
pregnant women with limited risk for possible exposure who are first evaluated 2 to 12 weeks after their last 
possible exposure should first receive a Zika virus IgM antibody test; if the IgM antibody test result is positive or 
equivocal (unclear), serum and urine RNA NAT should be performed. Asymptomatic pregnant women with 
ongoing risk for possible exposure to Zika virus should receive Zika virus IgM antibody testing as part of routine 
obstetric care during the first and second trimesters; immediate RNA NAT testing should be performed when IgM 
antibody test results are positive or equivocal (unclear). 
 
Further information on the interpretation of laboratory test results and clinical management of pregnant women 
with laboratory evidence of possible Zika virus infection are available below. 
 
For More Information 
•        Interim Guidance for Health Care Providers Caring for Pregnant Women: 
 MMWR:  http://www.cdc.gov/mmwr/volumes/65/wr/mm6529e1.htm?s_cid=mm6529e1_w  
 Summary:  http://www.cdc.gov/zika/hc-providers/pregnant-woman.html  
•      Fact Sheet with Testing Algorithms: http://www.cdc.gov/zika/pdfs/testing_algorithm.pdf  
  Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus 
for Persons with Possible Zika Virus Exposure — United States, September 2016 | MMWR 





The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 





Categories of Health Alert Network messages:  
Health Alert  Requires immediate action or attention; highest level of importance 
Health Advisory May not require immediate action; provides important information for a specific incident or situation 
Health Update   Unlikely to require immediate action; provides updated information regarding an incident or situation 
HAN Info Service Does not require immediate action; provides general public health information 
 
##This message was distributed to state and local health officers, state and local epidemiologists, state and local 
laboratory directors, public information officers, HAN coordinators, and clinician organizations## 
 
